Skip to content

Clinical trials

Phase 3 Muscular Dystrophies trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophies Phase: Phase 3 Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20132
20141
20181
20191
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Catabasis Pharmaceuticals2
GlaxoSmithKline2
PTC Therapeutics2
Avidity Biosciences, Inc.1
Fulcrum Therapeutics1
Sarepta Therapeutics, Inc.1
University of Rochester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophies10
Muscular Dystrophy, Duchenne9
Neuromuscular Diseases7
Musculoskeletal Diseases6
Genetic Diseases, Inborn3
Muscular Diseases3
Muscular Disorders, Atrophic3
Nervous System Diseases3
Genetic Diseases, X-Linked2
Infant, Newborn, Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.